Quantum BioPharma Q3 Financial Report: Achieved $572,000 in Revenue through Digital Asset Portfolio

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.

The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.